The details of the patient selection have been described previously.
13 In short, 76 persons divided into four groups each consisting of 19 persons were studied. Group A consisted of normal persons without any known systemic or ocular disease, whereas the other three groups consisted of type 2 diabetic patients. Group B had no retinopathy in either eye, group C had mild retinopathy (1–4 dot and/or blot hemorrhages) in at least one eye, and group D had diabetic maculopathy in at least one eye. All groups were pair-wise matched with respect to age (56.2 ± 1.2 years, overall mean ± SEM) and sex, and additionally the diabetic patients were matched with respect to known duration of diabetes mellitus (9.5 ± 1.2 years, overall mean ± SEM). There was no significant difference between the groups (overall mean ± SEM,
P value for groups comparisons) for plasma glucose (10.5 ± 1.0 mM/L,
P = 0.69), HbA1c (7.9 ± 0.3%,
P = 0.41), total cholesterol (5.1 ± 0.2 mMl/L,
P = 0.54), body mass index (29.0 ± 0.9 kg/m
2,
P = 0.17), systolic (135 ± 3.8 mm Hg,
P = 0.19), or diastolic (85 ± 2.4 mm Hg,
P = 0.70) blood pressure.
13 There was no correlation between any of these clinical and biochemical parameters and the diameter measurements and measures of fluctuation derived from these. In preliminary experiments the variation in diameter measurements of retinal arterioles had been found to be 0.06% (confidence interval [CI] 95%: −0.92; 1.04) with a Pearson correlation of 0.99 [CI 95%: 0.98; 0.99]. Consequently, in a double-sided
t-test and with a power of 70%, it would be necessary to include 17 persons in each group in order to detect a 2% change in the vessel diameter.